Upon cell entry, herpesviruses deliver a multitude of premade virion proteins to their hosts. The interplay between these incoming proteins and cell-specific regulatory factors dictates the outcome of infections at the cellular level. Here, we report a unique type of virion-host cell interaction that is essential for the cell cycle and differentiation state-dependent onset of human cytomegalovirus (HCMV) lytic gene expression. The major tegument 150-kDa phosphoprotein (pp150) of HCMV binds to cyclin A2 via a functional RXL/Cy motif resulting in its cyclin A2-dependent phosphorylation. Alanine substitution of the RXL/Cy motif prevents this interaction and allows the virus to fully escape the cyclin-dependent kinase (CDK)-mediated block of immediate early (IE) gene expression in S/G2 phase that normally restricts the onset of the HCMV replication cycle to G0/G1. Furthermore, the cyclin A2-CDKpp150 axis is also involved in the establishment of HCMV quiescence in NTera2 cells, showing the importance of this molecular switch for differentiation state-dependent regulation of IE gene expression. Consistent with the known nucleocapsid-binding function of pp150, its RXL/Cy-dependent phosphorylation affects gene expression of the parental virion only, suggesting a cis-acting, virus particle-associated mechanism of control. The pp150 homologs of other primate and mammalian CMVs lack an RXL/Cy motif and accordingly even the nearest relative of HCMV, chimpanzee CMV, starts its lytic cycle in a cell cycle-independent manner. Thus, HCMV has evolved a molecular sensor for cyclin A2-CDK activity to restrict its IE gene expression program as a unique level of selflimitation and adaptation to its human host. H erpesviruses are highly adapted to their hosts. This is due to a long coevolutionary process and based on an intricate molecular virus-host interaction network. Interestingly, a significant fraction of herpesviral gene products is already present in the very first phase of infection, after virus entry but before the onset of de novo viral gene expression. These factors originate from the tegument, a characteristic, protein-rich layer within herpesvirus particles, occupying the space between nucleocapsid and virus envelope. Tegument proteins serve a number of important functions. They are involved in the cytoplasmic transport of nucleocapsids, nuclear delivery of viral genomes, immune evasion, and transactivation of immediate early (IE) gene transcription (1). Importantly, they also provide a unique opportunity for the virus to flexibly respond to different cell types and states immediately after entry and set the course for a productive or nonproductive infection at the earliest possible stage.
Upon cell entry, herpesviruses deliver a multitude of premade virion proteins to their hosts. The interplay between these incoming proteins and cell-specific regulatory factors dictates the outcome of infections at the cellular level. Here, we report a unique type of virion-host cell interaction that is essential for the cell cycle and differentiation state-dependent onset of human cytomegalovirus (HCMV) lytic gene expression. The major tegument 150-kDa phosphoprotein (pp150) of HCMV binds to cyclin A2 via a functional RXL/Cy motif resulting in its cyclin A2-dependent phosphorylation. Alanine substitution of the RXL/Cy motif prevents this interaction and allows the virus to fully escape the cyclin-dependent kinase (CDK)-mediated block of immediate early (IE) gene expression in S/G2 phase that normally restricts the onset of the HCMV replication cycle to G0/G1. Furthermore, the cyclin A2-CDKpp150 axis is also involved in the establishment of HCMV quiescence in NTera2 cells, showing the importance of this molecular switch for differentiation state-dependent regulation of IE gene expression. Consistent with the known nucleocapsid-binding function of pp150, its RXL/Cy-dependent phosphorylation affects gene expression of the parental virion only, suggesting a cis-acting, virus particle-associated mechanism of control. The pp150 homologs of other primate and mammalian CMVs lack an RXL/Cy motif and accordingly even the nearest relative of HCMV, chimpanzee CMV, starts its lytic cycle in a cell cycle-independent manner. Thus, HCMV has evolved a molecular sensor for cyclin A2-CDK activity to restrict its IE gene expression program as a unique level of selflimitation and adaptation to its human host. H erpesviruses are highly adapted to their hosts. This is due to a long coevolutionary process and based on an intricate molecular virus-host interaction network. Interestingly, a significant fraction of herpesviral gene products is already present in the very first phase of infection, after virus entry but before the onset of de novo viral gene expression. These factors originate from the tegument, a characteristic, protein-rich layer within herpesvirus particles, occupying the space between nucleocapsid and virus envelope. Tegument proteins serve a number of important functions. They are involved in the cytoplasmic transport of nucleocapsids, nuclear delivery of viral genomes, immune evasion, and transactivation of immediate early (IE) gene transcription (1) . Importantly, they also provide a unique opportunity for the virus to flexibly respond to different cell types and states immediately after entry and set the course for a productive or nonproductive infection at the earliest possible stage.
A compelling example for a tegument-derived sensor of the host cell milieu is the 71-kDa phosphoprotein (pp71, also referred to as the UL82 gene product "pUL82") of human cytomegalovirus (HCMV, human herpesvirus 5), a widespread human pathogen. Permissiveness for HCMV depends on the cellular differentiation state (2) and is intimately linked to the regulation of viral IE gene expression. In differentiated cells, pp71 translocates to the nucleus after virus entry and associates with nuclear domain 10 (ND10)-structures, where it prevents histone deacetylase (HDAC)-mediated IE gene silencing by neutralizing the ATRX-Daxx repressor complex (3, 4) . In contrast, in undifferentiated cells, like CD34+ hematopoietic progenitors or embryonic cell lines, pp71 remains cytoplasmic and consequently a quiescent or latent mode of infection is favored (5, 6) .
The cell cycle state is another important host determinant in the pre-IE phase of HCMV infection. In S/G2 cells, a general block to IE gene transcription is installed after virus entry (7, 8) . This block is HDAC-independent and can be relieved by inhibition of cyclin-dependent kinases 1 and 2 (CDK1/2). Of note, CDK1/2 inhibition also promotes IE gene expression in undifferentiated cell lines of embryonic origin, suggesting a unifying mechanism of virus control (9) . Cyclin A2 has recently been identified as the key regulator that recruits CDK1/2 for inhibition of the HCMV lytic cycle (10) . The cyclin A2-CDK substrate, however, mediating these effects is still unknown.
Here we followed the rationale that a viral tegument factor sensitizes HCMV for the cellular cyclin A2-CDK status. We found that the major tegument phosphoprotein pp150 of HCMV functions as a cyclin A2-specific CDK substrate and that the pp150-cyclin A2 interaction is absolutely essential for the cell cycle-dependent block of viral gene expression. We further provide evidence that the pp150-and pp71-based mechanisms cooperate in selecting undifferentiated cells as sites for HCMV
Significance
Depending on the host cell type and differentiation status, herpesviruses establish different modes of infection to either maintain or replicate their genomes. How viruses discriminate between individual host cell environments upon infection is poorly understood. Here we identify a viral sensor mechanism that restricts human cytomegalovirus (HCMV) replication to the G0/G1 phase of the cell division cycle and to differentiated cells. The mechanism is based on the HCMV tegument 150-kDa phosphoprotein which enters the cell as a constituent of the virus particle, interacts with cyclin A2, and blocks the onset of viral lytic gene expression when cyclin A2-dependent kinase activity is high. This suggests a scenario where specific tegument-host interactions enable herpesviruses to select sites of silent or productive infection.
gene silencing. Taken together, our data define a molecular basis for the long-time enigmatic cell cycle and differentiation state dependency of HCMV-IE gene expression and strengthen the concept of tegument proteins acting as versatile regulators of herpesvirus infections.
Results
When we examined HCMV tegument proteins for possible targets of cyclin A2-CDK-dependent phosphorylation, we found that pp150, also referred to as the UL32 gene product "pUL32" or basic phosphoprotein, has all sequence features of a typical cyclin A2-CDK substrate. pp150 consists of a nucleocapsidbinding domain and a largely uncharacterized carboxy (C)-terminal part (Fig. 1A) . This latter region contains not only nine canonical (S/T-P-X-K/R) and a multitude of minimal (S/T-P) CDK-phosphoacceptor sites, but also a putative cyclin A2-binding sequence (RRLFG) identical or nearly identical to the prototypical RXL/Cy motifs of pocket proteins (p107, p130) and Cip/Kip-type CDK inhibitors (Fig. 1B) . RXL/Cy motifs are fundamental for specific substrate recognition by cyclin A2 as they make direct contact with its substrate docking site (11) .
To directly test whether pp150 can interact with cyclin A2, we performed a pull-down experiment, using purified, amino (N)-terminally truncated versions of pp150 (Fig. 1C) . We found that pp150 wild-type but not an RXL-mutant form was able to precipitate cyclin A2 from cell extracts. With a substrate bindingdeficient cyclin A2 hydrophobic patch mutant (11) the pull-down efficiency was reduced to background levels (Fig. 1D) . The specificity of pp150-cyclin A2 binding was further demonstrated by the failure of cyclin B1 to coprecipitate with pp150 ( Fig. 1E) . Cyclin B1 binds inefficiently to RXL/Cy motifs (12) and hence its substrate spectrum only partially overlaps with cyclin A2 (13) .
To address whether the RRLFG-mediated recruitment to cyclin A2 also results in pp150 phosphorylation, we carried out kinase assays, including histone H1 as a control. Histone H1 is an RXL/Cy motif-independent CDK substrate (11) and accordingly can be phosphorylated by both cyclin A2-and B1-associated kinases with similar efficiency (14) . pp150 and histone H1 were equally well phosphorylated in our assay, but in contrast to histone H1, pp150 phosphorylation proved to be cyclin A2-specific and occurred in a strictly RXL-dependent manner (Fig. 1F) . Thus, pp150 qualifies as a specific cyclin A2-CDK substrate.
To analyze the functional relevance of pp150-cyclin A2 interaction for the cell cycle-dependent control of IE gene expression, we introduced the RRLFG AAAAA mutation into the HCMV genome by means of markerless BAC mutagenesis. We examined two independently created pp150-RXL mutant viruses (RV1659, RV3301) and immediately recognized that both had completely lost the characteristic G1-restricted expression pattern of major IE proteins IE1 and IE2 ( Fig. 2A) . Instead IE1/IE2 expression was started with equal efficiency throughout the cell cycle. This was a direct consequence of pp150-RXL mutation and not of other, unrecognized secondary mutations somewhere else in the genome, as the revertant viruses regained the normal, cell cycle-dependent expression pattern of parental HCMV ( Fig.  2A) . We concluded that pp150 constitutes a crucial, cyclin A2-sensitive regulatory switch that is responsible for the block of viral gene expression in S/G2.
To directly link the pp150-mediated regulation of IE gene expression to the cellular cyclin A2-CDK status, we analyzed the effects of pp150-RXL mutation in a recently established cell system where ectopic expression of a stable cyclin A2 variant (CycA2ΔD) leads to inhibition of HCMV gene expression in all cell cycle phases (10) . The results were clear-cut. The pp150-RXL mutant virus was not only able to overcome the S/G2-specific block of IE gene expression in unmodified, HCMVpermissive U373 cells, but also the constitutive block in the CycA2ΔD-transduced derivatives (Fig. 2B) . The negative effects of cyclin A2 overexpression on HCMV-WT were also relieved when using the CDK-binding deficient point mutant CycA2ΔD (R211A). Taken together, these findings show that pp150 is the critical mediator between cyclin A2-CDK-dependent phosphorylation and IE gene repression.
Despite the presence of a pp150 homolog (M32), gene expression of murine CMV (MCMV) occurs both in a cell cycle and cyclin A2-independent manner (10, 15) . Aiming for evolutionary insight into HCMV's cell cycle dependency, we compared known pp150 homologs of mammalian CMVs. Whereas the N-terminal capsid-binding domain is conserved across all species (16), the C-terminal part is highly divergent in size, sequence, and number of potential CDK-phosphoacceptor sites (Fig. 3A) . Strikingly, none of the animal homologs possess an RXL/Cy motif. This also applies to chimpanzee CMV (CCMV), which is the closest relative of HCMV (17) and displays the highest similarity to the pp150 C terminus (Fig. 3 A and B) . Accordingly and despite the presence of multiple CDK consensus sites, CCMV was found to behave like MCMV, starting its IE gene expression with the same efficiency in the G0/G1 and S/G2 cell cycle compartments (Fig.  3C) . This emphasizes the functional importance of the pp150-RXL/Cy motif and strongly suggests that the cyclin A2-pp150-driven control of viral gene expression is an exclusive feature of HCMV.
The silencing of lytic gene expression in stem and progenitor cells is a hallmark of HCMV infection and a prerequisite for virus latency (18) . We reported previously that cellular CDK activity contributes to HCMV gene silencing in pluripotent NTera2/D1 (NT2) cells (9), a model system for the establishment phase of latent-like infections (2) . This prompted us to investigate the potential impact of pp150-cyclin A2 binding on the differentiation-dependent control of IE gene expression. We found that the pp150-RXL mutation can functionally replace CDK inhibition in undifferentiated, Oct3/4-positive NT2 cells, preventing IE gene silencing to a similar degree as roscovitine or related compounds (Fig. 4) . However, the low penetrance of the RXL mutation-based rescue effect, exceeding hardly 5-10% of cells, pointed to the presence of further CDK-independent silencing mechanisms. One of those mechanisms is known to act at the chromatin level and can be overcome by HDAC inhibitor treatment (19) . As the effect of HDAC inhibition alone was also limited and became visible only in around 10% of cells (Fig. 4) , we reasoned that both mechanisms might act synergistically. This hypothesis was tested by combining HDAC inhibitor treatment with either pp150-RXL mutation or CDK inhibition. Both combinations resulted in a significant and far more than additive increase in the percentage of IE-positive cells, approximating the numbers observed after retinoic acid-induced differentiation (Fig. 4). Thus, the pp150-cyclin A2 interaction motif belongs to one of several independent mechanisms used by HCMV to block the onset of lytic gene expression and to establish a quiescent state of infection in undifferentiated cells.
To gain insight into the working principle of pp150-mediated control in the pre-IE phase of infection, we addressed the question as to whether pp150 acts in trans like other CMV tegument proteins with known regulatory function or in cis, as suggested by its tight interaction with capsids in vitro (16) and its localization within the inner, detergent-resistant tegument layer of virus particles (20) . We designed a coinfection experiment where pp150-WT and pp150-RXL mutant viruses were tested for their ability to influence each other in the presence or absence of cyclin A2-CDK activity. To allow specific assignment of IE gene products to one or the other virus we used a pp150-WT virus (RV2042) encoding a size-distinguishable IE2-red fluorescent protein 611 (RFP611) fusion protein. It turned out that after coinfection of cyclin A2-overexpressing cells (CycA2delD) each virus behaved exactly like in single infections (Fig. 5A) . Neither is IE2-RFP611 expression of RV2042 rescued by the presence of the cyclin A2-insensitive pp150-RXL mutant virus nor is IE2 expression of the RXL mutant virus compromised by the pp150-WT protein delivered by RV2042. This finding suggests a cisacting mechanism of pp150-mediated control where only the genome derived from the same parental virion is affected. Such a particle-associated mode of regulation is further supported by an independent approach based on fluorescence microscopy. This shows discrete and clearly distinct foci representing differentially tagged pp150 fusion proteins in both cyclin A2-overexpressing and control cells coinfected with pp150-GFP and pp150-RFP containing HCMV variants (Fig. 5B) . We propose a model where cyclin A2-CDK-dependent phosphorylation of pp150 controls a yet undefined step, taking place after virus entry but before final disassembly of the virus particle (Fig. 5C ).
Discussion
The finding that pp150 acts as a cyclin A2 substrate and powerful cis-acting regulator in the pre-IE phase of infection provides a long-sought clue to understanding the cell cycle and differentiation state dependence of HCMV. It complements previous studies on the role of p53-p21-CDK signaling (9, 10) by adding a viral sensor molecule to this pathway. It explains why MCMV, used in the most common animal models of HCMV infection, was found to be less sensitive to varying cell cycle conditions and differentiation states (10, 15, 21) and it helps to understand the limited efficacy of HDAC inhibition or Daxx knockdown in desilencing IE gene expression in pluripotent cells (6) .
pp150 is an example of a capsid-associated tegument protein with regulatory function. Other tegument-derived regulators of IE gene expression are loosely packed within the tegument, become displaced from the virion after cell entry, and move toward the nucleus independently from microtubule-mediated capsid transport (1) . In contrast, pp150 remains virus particle bound and accordingly has been used in a number of fluorescence microscopy studies to monitor HCMV capsids in the initial phase of infection (22) (23) (24) . Of note, and in agreement with our own data (Fig. 5B) , pp150 foci are not restricted to the cytoplasm but also appear in the nuclei of permissive cells. This is reminiscent to the nucleocytoplasmic distribution of newly synthesized pp150 at late stages of infection (25, 26) . Considering that nuclear entry of herpesvirus genomes relies on capsid disassembly at nuclear pores (27) , the composition of pp150 containing nuclear structures at pre-IE times is yet unclear. The finding that pp150 molecules from different virus particles do not reassort after nuclear translocation (Fig. 5B) suggests that pp150 remains attached or reassembles to one or several constituents of the parental particle during nuclear entry. As nuclear entry of viral DNA is only marginally influenced by the cell cycle phase (7) and pp150 exerts cis-acting control on viral gene expression (Fig. 5A ), it appears likely that nuclear pp150 is part of a viral genome comprising regulatory structure. Given that PML and Daxx knockdown has no influence on IE gene repression in S/G2 (7), it is tempting to speculate that these structures account for the fraction of HCMV genomes that enter the nuclei of infected cells but are not deposited at ND10 (28) . Work is ongoing in our laboratory to address this issue.
Phosphorylation is a rapid and reversible way to modulate activity, structure, or localization of proteins. Although phosphoproteins are abundantly present in the HCMV tegument (pp150, pUL69, pp71, pp65, pUL97, pp28) the functional implications of their phosphorylation status for the pre-IE phase of infection is poorly understood (1). To date, there is only one report, suggesting that virion incorporation of hypophosphorylated pp28 delays the onset of IE gene expression by decreasing the stability of pp28 and pp65 in newly infected cells (29) . Our results directly link phosphorylation of pp150 to the negative control of IE gene expression in S/G2 and undifferentiated cells. To be sensitive for different cyclin A2-CDK activity levels, pp150 may need to enter the host cell with un-(or hypo-) phosphorylated CDK-phosphoacceptor sites. The down-regulation of cyclin A2 expression in the earlylate phase of infection (30) and the virion incorporation of cellular serine/threonine protein phosphatases PP1 and PP2A (31) are likely to contribute to such a CDK-sensitive state of pp150. Alternatively, the dynamic equilibrium of cyclin A2-CDK and counteracting phosphatases in the host cell (32) regulates incoming pp150, independent of its phosphorylation status in the virion. It will be interesting to see which of the overall 31 possible CDK-phosphorylation sites (S/TP) in the pp150 C-terminal domain are used by cyclin A2-CDK and which are critical for pp150 function.
During the course of lytic replication, pp150 expression occurs with true late kinetics and plays an essential role in nucleocapsid trafficking, stability and virus maturation (33, 34) . Mutation of the pp150-RXL/Cy motif does not impair virus growth, indicating that the pp150-cyclin A2 interaction site has been acquired by HCMV solely for regulation of IE gene expression. So what is the evolutionary advantage of this self-imposed cyclin A2-CDK sensitivity? One possibility is that it contributes to the selection of host cells suitable for latent infection. For example, hematopoietic progenitor cells, a major site of latency for HCMV, are characterized by constitutive cyclin A2 expression (35) . In addition, pp150 may be part of a general strategy of cyclin A2 avoidance that helps to prevent unwanted, cyclin A2-driven processes like cellular DNA synthesis and mitotic entry during progression of the lytic cycle. Defining the viral factor(s) responsible for cyclin A2 repression after the onset of IE gene expression will be important to complete our understanding of this molecular interface between HCMV and the cell division cycle.
Materials and Methods
Cells and Viruses. Human embryonic lung (HEL) fibroblasts (Fi301), NT2, and lentivirus-transduced U373 cells were described previously (9, 10) . Where indicated, cells were treated with roscovitine (Santa Cruz), CVT313 (Merck), SU9516 (Santa Cruz), retinoic acid, or TSA (Sigma-Aldrich). CCMV was kindly provided by Gary Hayward (Johns Hopkins School of Medicine, Baltimore, MD). HCMV-TB40-BAC4 (36) and HCMV-TB40-UL32-EGFP (23) were gifts from Christian Sinzger (Universitätsklinikum Ulm, Germany). All other recombinant viruses were derived from TB40-BAC4 by BAC mutagenesis (see SI Materials and Methods). Viruses were propagated on HEL fibroblasts and titered as previously described (9) . A multiplicity of infection (MOI) of 5-10 IE-protein forming units per cell was used for experiments.
BAC Mutagenesis. For a detailed description of BAC-mutagenesis, see SI Materials and Methods.
Recombinant Protein Production. An N-terminally truncated pp150 coding sequence was amplified from bacmids TB40-BAC4 and RV3301 respectively, using primers UL32(907)fw-Bam and UL32(1047)rev-Bam (Table S1 ). After BamH1-mediated insertion into the prokaryotic expression vector pET-52b(+) (Merck), the resulting constructs pET-52b(+)-pp150c and pET-52b(+)-pp150c-RXLmut were transformed into Escherichia coli BL21-CodonPlus (DE3)-RIPL (Stratagene). Cells were grown overnight in 25 mL Luria-Bertani (LB) medium containing 100 μg/mL ampicillin and 50 μg/mL chloramphenicol. Subsequently, cells were transferred to 500 mL LB medium/ampicillin and grown at 37°C until midphase of logarithmic growth. At this point, pp150 expression was induced by addition of isopropyl-β-D-1-thiogalactopyranoside to a final concentration of 0.15 mM. After a 5-h induction period at 25°C, cells were harvested by centrifugation and suspended in buffer A (0.3 M NaCl, 50 mM NaH 2 PO 4 , 20 mM imidazole, pH 8.0), supplemented with 10 μg/mL leupeptin, 0.1 mM pefabloc, 1 μM pepstatin, and 2 μg/mL apronitin. Cells were lysed on ice by sonication and the cleared lysate was incubated for 2 h with preequilibrated Ni-NTA agarose beads (Qiagen). The His-pp150c-bound beads were washed seven times with buffer A containing up to 70 mM imidazole. Protein yield and purity were evaluated by SDS-polyacrylamide gel electrophoresis (PAGE) and Coomassie staining.
His-Pull Down Assay. Coding sequences for cyclin A2, cyclin A2-hpm, and cyclin B1 were amplified from plasmids pcDNA3-cyclinA-HA, pcDNA-cyclinAhpm-HA (11), and pCMX-cyclin B1 (37) and subcloned into the eukaryotic expression vector pCI-neo (Promega), in-frame to an N-terminal triplehemagglutinin (3HA) epitope tag. The resulting plasmids were confirmed by sequencing, purified by CsCl ethidium bromide equilibrium centrifugation, and transfected into HEK293 cells using Turbofect (Fermentas). Two days post transfection, cells were harvested, suspended in immunoprecipitation (IP) buffer [50 mM Tris (pH 7.6), 10 mM MgCl 2 , 150 mM NaCl, 5% (vol/vol) glycerol, 0.05% Tween 20, 1 mM Na 3 VO 4 , 1 mM NaF, 1 mM DTT], and disrupted by freezing and thawing. Soluble extract protein (150 μg) was diluted with IP buffer to 1 μg/μL, supplemented with 20 mM imidazole, and incubated with 10 μL of His-pp150c beads (see Recombinant Protein Production) for 1.5 h at 4°C. Afterward, beads were washed six times with IP buffer/20 mM imidazole, boiled in Laemmli buffer, and subjected to immunoblot analysis.
Immunoblot Analysis. U373 whole cell lysates were prepared and adjusted to equal protein concentrations as recently described (10) . Immunoblot analysis was carried out as described (38) , using antibodies against IE2 (clone 12E2, Fig. 2 legend) were synchronized in G1 by contact inhibition and then infected with equal amounts of (A) RV2042 and RV3301 or (B) pp150-GFP and pp150-RFP expressing HCMV-TB40 derivatives. RV2042 encodes an IE2-FP611 fusion protein, RV3301, the pp150-RXLmutant as described in the Fig. 2 legend. (A) At 4 h postinfection, IE2, cyclin A2, and GAPDH protein level were analyzed by immunoblotting. (B) At 3 h postinfection, cells were analyzed by confocal immunofluorescence microscopy for pp150-GFP (green foci) and pp150-RFP (red foci) localization. Nuclei were counterstained by DAPI. Representative images are shown (B, Upper). Based on at least 50 randomly selected cells per sample, the average percentages of nuclear or cytoplasmic-localized red, green and yellow (merged) foci were quantified (B, Lower). Nuclear localization of pp150 was defined by its fluorescence overlap with DAPI. (C) Schematic representation of pp150 as a cyclinA2-CDK-dependent, cis-acting molecular switch controlling the onset of IE gene expression from the parental viral genome.
